Pregabalin Capsule
Product Images NDC 70518-4585

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 70518-4585). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description of Pregabalin Capsule C-V containing 50 mg, with 90 capsules per quantity. The NDC number is 70518-4585-00. It is a white capsule with the imprint "139 B renack". The drug is for prescription use only, and caution is advised against transferring it to anyone other than the patient. The manufacturer is Camber Pharma, Inc, with a contact in Piscataway, NJ 08854. The medication should be stored at 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F) as per USP guidelines.*

FDA Label Image

Pregabalinfigure1 (Pregabalinfigure1)

FDA Label Image

Pregabalinfigure10 (Pregabalinfigure10)

FDA Label Image

Pregabalinfigure11 (Pregabalinfigure11)

FDA Label Image

Pregabalinfigure12 (Pregabalinfigure12)

This text mentions the percentage of subjects who improved from baseline to week 16 based on the BOCF (Baseline Observation Carried Forward) method. A quantitative evaluation is provided, but exact details are not clear due to the mix of characters and symbols.*

FDA Label Image

Pregabalinfigure2 (Pregabalinfigure2)

This text provides information on the percentage of patients improved with Pragabalin 106 mg taken three times a day. It also shows data on the percentage improvement in pain from baseline.*

FDA Label Image

Pregabalinfigure3 (Pregabalinfigure3)

FDA Label Image

Pregabalinfigure4 (Pregabalinfigure4)

FDA Label Image

Pregabalinfigure5 (Pregabalinfigure5)

This text provides data on the percentage of patients improved with different treatments: Pregabalin 100mg three times a day, Pregabalin 60mg three times a day, and Placebo. The graph shows the improvement in pain from baseline.*

FDA Label Image

Pregabalinfigure6 (Pregabalinfigure6)

FDA Label Image

Pregabalinfigure7 (Pregabalinfigure7)

FDA Label Image

Pregabalinfigure8 (Pregabalinfigure8)

This text provides data on responder rates for different dosages in a study, including placebo doses. Responder rates are expressed as percentages for each dosage. Additionally, there seems to be a mention of placebo doses in mg/kg/day.*

FDA Label Image

Pregabalinfigure9 (Pregabalinfigure9)

FDA Label Image

Pregabalinstructure (Pregabalinstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.